Anna Nowocin
Head of Flow Cytometry Standardisation,
MHRA
Ibon Garitaonandia
Chief Scientific Officer,
CellProthera
Julia Matilainen
Head of Patient Operations CGT,
Roche
Kyle Zingaro
Head of Gene Therapy Process Sciences,
UCB
Lindsay Davies
Chief Scientific Officer,
NextCell Pharma AB
Muhammad Akram
Senior Medical Director,
Legend Biotech
Paolo Morgese
Vice President Public Affairs Europe,
Alliance for Regenerative Medicine
Rolf Koehler
Associate director,
Novartis
Ruben Rizzi
Senior Vice President Global Regulatory Affairs,
BioNTech SE
Sarah Albon
Director,
Cambridge University Hospitals NHSFT
Theodora Weisz
Head of Patient Advocacy and Public Affairs EMEA,
Novartis
Tim Allsopp
Chief Technology Officer,
Laverock Therapeutics
Aisling McMahon
Professor of Law,
Maynooth University
Akihiro Ko
Co-Founder & Chief Executive Officer,
Elixirgen Therapeutics Inc
Aline Miller
Principal Investigator, Professor of Biomolecular Engineering and Associate Dean for Business Engagement and Innovation,
University of Manchester
Anton Hutter
Partner, Patent Attorney,
Venner Shipley IP
Brian Philip
Primary Scientist,
NIBRT
Catia Andreassi
Director,
AviadoBio
Charlotte Wilding
Patent Attorney,
Venner Shipley
Charlotte Serra
Vice President, Head of Quality Assurance, Cellular Therapy,
Galapagos
Chrysanthi Sitmalidou
Scientist II,
Orchard Therapeutics
Darius Widera
Professor of Stem Cell Biology and Regenerative Medicine,
University of Reading
Darren Nesbeth
Associate Professor,
UCL
Djordje Djordjevic
Co-founder + CEO,
Plurify
Dolores Schendel
Chief Scientific Officer,
Medigene AG
Elena Piletska
Associate Professor in Bioanalytical Chemistry,
University of Leicester
Eleonora Zucchelli
Senior Scientist,
Cell and Gene Therapy Catapult
Eli Gilsohn
VP, Intellectual Property,
Resolution Therapeutics
Emilie Gauthy
Head of CMC,
Zelluna Immunotherapy
Emma Chan
Director of Process & Analytical Development,
Orchard Therapeutics
Francesco Dazzi
Executive Medical Lead Cell Therapies,
AstraZeneca
Gabriel Kent
Analytical Development Scientist,
Resolution Therapeutics
Gearóid Duane
Senior Principal Scientist,
Bristol Myers Squibb
Himansu Patel
Head of Quality Innovation,
Cell & Gene Therapy Catapult
James Carlson
Principal Safety Director ATMP Enablement,
Roche
Jas Uppal
Founder and CEO,
BQP Consultancy
John Garcia
Head of New Manufacturing Technologies,
UCL
John H Wolfe
Professor,
Child Hosp Philadelphia
Jose Bonafont Arago
Senior Scientist,
DanausGT
Kelly Evans
Senior Scientist,
AstraZeneca
Kirsty Crame
VP Clinical Strategy & Development,
Medigene AG
Klara Kulenkampff
Project Manager,
Bayer
Lucy Williams
Partner,
J A Kemp LLP
Luis Ayala
Scientist Perfusion Systems,
Merck KGaA
Luz Alonso-Crisostomo
Senior Scientist,
AstraZeneca
Mana Yen
Gene Therapies & Rare Diseases - Global Head of Health Systems,
Novartis Gene Therapies
Manuel Carrondo
senior vp,
IBET
Marc Schneider
Director Product Supply,
BioNTech SE
Marcel van Houten
Director Global Supply Chain,
Orchard Therapeutics Ltd
Maria Luisa Giorello
Global Gene Therapy Platform Enablement Director,
Pfizer Ltd
Marina Tarunina
Research Director,
Plasticell Ltd
Martin Dass
Scientist,
Boehringer Ingelheim Pharma GmbH & Co. KG
Matthew Gibson
Professor,
University of Manchester
Matthew Garner
Head of Intellectual Property,
Catapult
Menasheh Fogel
IT Head, Cell and Gene Therapy,
Bayer
Millie Fox
Senior Scientist,
AstraZeneca
Molly Stevens
John Black Professor of Bionanoscience,
University of Oxford
Monica Raimo
Sr. R&D Manager,
Glycostem Therapeutics
Mustafa Munye
Vice President Operations,
Complement Therapeutics
-1.webp?length=600&name=main-qimg-6c062adcbace942e5c2a2ea3ec7caf5a%20(1)-1.webp)
Nicolas Weber
Quality Team Leader QC,
Novartis Pharma
Nirai Govindasamy
Senior Scientist,
Bluu Seafood
Patricia Mendoza
Senior Scientist,
AstraZeneca
Patrizia Ferretti
Professor of Regenerative Biology,
University College London
Philippe Henon
Chairman,
CellProthera
Rahul Khetan
Venture Capital Associate,
UCB Ventures
Raiko Stephan
Gene & Cell Therapy Lead,
Novartis
Richard Porter
cbso,
uniQure
Roshni Desai
Nonclinical Assessor,
MHRA
Ruth Faram
Co-Founder & Chief Scientific Officer,
HigherSteaks
Sakis Mantalaris
Professor,
Trinity College Dublin & NIBRT
Sam Goldsmith
Head of Commercialisation of Research & Investments,
CGT Catapult
Sarah Snykers
Director of Operations,
Legend Biotech
Sarah Howlett
Associate Director,
AstraZeneca
Sergey Piletsky
Professor in Bioanalytical Chemistry,
University of Leicester
Simon Chandler
CEO,
Rinri Therapeutics
Stephen Sullivan
Chief Operating Officer & Board Member,
iPSirius
Subhankar Mukhopadhyay
Senior Lecturer/Associate Professor,
King's College London
Sujith Sebastian
Viral Vector Hub Manager,
NHSBT
Terri Gaskell
Chief Technical Officer,
Rinri Therapeutics
Ulrich Dr. Rümenapp
Senior Biotech Program Lead,
Bayer AG
Uwe Buecheler
Senior Advisor - Biopharmaceuicals,
Boehringer Ingelheim
Vicki Coutinho
Managing Director & Consultant,
Geni Consulting
Wonjong Si
Associate Director, Cell Therapy Platform Process,
Bayer
Xavier Fontana
Principal Scientist,
Adaptimmune
Yen Choo
Founder & Chairman; Associate Professor of Stem Cell Science and Regenerative Medicine,
Plasticell; Lee Kong Chian School of Medicine Science